Brighthouse Q3 Net Income Falls to $302M as Merger Slips

Brighthouse Financial, Inc. (Nasdaq: BHF) reported third quarter 2026 net income available to shareholders of $302 million, or $5.21 per diluted share, the company announced on 5 November 2026, down from $453 million, or $7.89 per diluted share, in the same quarter a year earlier. Adjusted earnings, which strip out market volatility and other items, fell to $527 million, or $9.12 per diluted share, from $970 million, or $16.87 per diluted share. The insurer also said its pending $70.00-per-share all-cash merger with an Aquarian Capital affiliate is unlikely to close by its 6 December 2026 outside date.

Context — Why Brighthouse's Q3 Results Matter Now

The quarter's headline decline is largely an accounting comparison, not an operating collapse. Both periods include a GAAP annual actuarial review that the company completes each third quarter, and the size of that adjustment drives most of the year-over-year gap. In the 2026 quarter, the review produced a net favorable impact of $278 million to net income available to shareholders, the company said.

On an adjusted basis, the current quarter carried $314 million of net favorable notable items, or $5.42 per diluted share, against $709 million, or $12.33 per diluted share, a year earlier. Stripping those out, adjusted earnings, less notable items, were $213 million, or $3.68 per diluted share, versus $261 million, or $4.54 per diluted share, in the third quarter of 2025. That is the cleanest read on the underlying run rate.

The pending merger adds a second layer of uncertainty. Aquarian Capital, described by the company as a diversified global holding company with insurance and asset management businesses, agreed in November 2025 to acquire Brighthouse for $70.00 per share in an all-cash transaction valued at roughly $4.1 billion. Insurance regulatory approvals in Delaware, New York and Massachusetts remain outstanding.

Brighthouse said on 6 September 2026 the merger agreement was automatically extended to 6 December 2026. The company now says those approvals are not expected in time to close by that date, and that it and Aquarian are discussing an amendment to push the outside date further. It cautioned there is no assurance an extension will be agreed or that the deal closes at all.

For a life insurer trading on a fixed cash consideration, that regulatory timeline is the dominant variable. Everything in the operating release matters less to the share price than whether the $70.00 deal holds.

Data — What the Numbers Show

Annuity sales totaled $2.4 billion, flat sequentially but down 12% quarter-over-quarter and 8% year-to-date, dragged by lower fixed annuity sales and partly offset by $2.1 billion of Shield Level Annuities. Life sales were $36 million, down 8% sequentially and 5% quarter-over-quarter, flat year-to-date.

Segment adjusted earnings split sharply. Annuities earned $301 million, versus $304 million a year earlier and $349 million in the second quarter of 2026. Life swung to $91 million from $40 million a year ago and an adjusted loss of $4 million last quarter. Run-off earned $166 million, against $641 million a year earlier and a $56 million adjusted loss in the prior quarter. Corporate & Other posted a $31 million adjusted loss.

Metric	Q3 2026	Q3 2025
Net income	$302M	$453M
Adjusted earnings	$527M	$970M
Adjusted EPS	$9.12	$16.87
Adjusted EPS, less notable items	$3.68	$4.54
Book value per share	$57.59	$81.60

Book value was $3.3 billion, or $57.59 per common share, down from $4,664 million, or $81.60 per share. Book value excluding AOCI was $9.3 billion, or $161.36 per share, up from $8,684 million, or $151.94 per share.

Net investment income was $1,257 million; adjusted net investment income was $1,310 million, down $17 million quarter-over-quarter on lower average assets but up $71 million sequentially on higher alternative investment income. The adjusted net investment income yield was 4.41%.

Analysis — What It Means for Markets and Sectors

The capital picture is the second story. Brighthouse reported preliminary statutory combined total adjusted capital of $4.8 billion, down from $4.9 billion at 30 June 2026 and $5.4 billion a year earlier. Its estimated combined RBC ratio sits between 415% and 435%, inside the company's stated 400%-450% target range for normal markets.

That ratio benefited from a $600 million extraordinary dividend paid by Brighthouse Reinsurance Company of Delaware to Brighthouse Life Insurance Company during the quarter. It absorbed negative hits from core results, basis risk and a significant rise in interest rates, plus a statutory reserve increase from the annual actuarial review and full implementation of the NAIC's new Generator of Economic Scenarios framework for variable annuity and Shield products. Holding company liquid assets were $1.0 billion.

The reserve build tied to the GOES framework is a sector-wide item, not a Brighthouse-specific one. Any US life insurer writing variable annuities or buffered products faces the same scenario-generator transition, and Brighthouse's disclosure gives a read on how costly that adoption is proving.

The counter-argument: the operating miss is modest once the actuarial review is stripped out. Adjusted earnings, less notable items, fell about 18% year-over-year, and the sequential rebound in alternative investment income shows the portfolio still earning. A reader who focuses only on the headline $302 million net income figure will overstate the deterioration.

Positioning is dominated by the merger spread. With a fixed $70.00 cash price and a deal that may slip past 6 December, the shares trade on deal-completion probability rather than on annuity sales momentum. That crowds out fundamental buyers and keeps the register in the hands of merger-arbitrage accounts.

Outlook — What to Watch Next

Three catalysts matter. First, any amendment to the merger agreement extending the outside date beyond 6 December 2026, which the company said it is discussing with Aquarian. Second, the Delaware, New York and Massachusetts insurance regulatory approvals, which remain the gating items. Third, fourth quarter annuity sales, to see whether Shield Level Annuities keep offsetting the fixed annuity decline.

On capital, the RBC ratio range of 415% to 435% is the level to track against the 400%-450% target band. A move toward the lower bound would put pressure on the $1.0 billion of holding company liquidity. The company gave no forward sales or earnings guidance in the release.

Frequently Asked Questions

What does Brighthouse Financial's Q3 2026 result mean for retail investors?

For anyone holding BHF, the operating numbers are secondary to the merger. Brighthouse agreed to be acquired for $70.00 per share in cash, so the shares track deal-completion odds, not quarterly earnings. The company said the deal will likely miss its 6 December 2026 outside date and that extension talks are underway, with no assurance of an agreement.

What happens next for Brighthouse Financial shareholders if the merger is not extended?

The company said either side may terminate the merger agreement if the closing has not occurred by the outside date. It also said all other closing conditions have been satisfied or waived, leaving the insurance regulatory approvals in Delaware, New York and Massachusetts as the remaining gating items. Brighthouse and Aquarian said they remain committed to the transaction.

Why did Brighthouse's adjusted earnings fall so much year-over-year?

Most of the drop traces to the annual actuarial review, which lands in the third quarter each year. The 2026 review produced $314 million of net favorable notable items, versus $709 million in 2025. Excluding those, adjusted earnings, less notable items, were $213 million, or $3.68 per diluted share, against $261 million, or $4.54 per diluted share, a year earlier.

Bottom Line

Brighthouse's underlying earnings slipped modestly, but its $70.00 Aquarian buyout now hinges on an extension past 6 December.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.